Granules India surges as its arm gets USFDA’s nod for Butalbital, Acetaminophen and Caffeine Capsules

09 Apr 2020 Evaluate
Granules India is currently trading at Rs. 174.50, up by 2.00 points or 1.16% from its previous closing of Rs. 172.50 on the BSE.

The scrip opened at Rs. 178.95 and has touched a high and low of Rs. 180.00 and Rs. 172.65 respectively. So far 115806 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 188.85 on 19-Feb-2020 and a 52 week low of Rs. 84.25 on 26-Jul-2019.

Last one week high and low of the scrip stood at Rs. 180.00 and Rs. 138.05 respectively. The current market cap of the company is Rs. 4487.47 crore.

The promoters holding in the company stood at 42.90%, while Institutions and Non-Institutions held 20.95% and 36.14% respectively.

Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals has received approval for its Abbreviated New Drug Application (ANDA) from the US Food and Drug Administration (US FDA) for Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg. It is bioequivalent to the reference listed drug product (RLD), Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg, of Nexgen Pharma, Inc.

Butalbital, Acetaminophen and Caffeine Capsules are used for the relief of the symptom complex of tension (or muscle contraction) headache. Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/300 mg/40 mg had U.S. sales of approximately $42 million MAT for the most recent twelve months ending in February 2020 according to IQVIA Health.

Granules now has a total of 25 ANDA approvals from US FDA (23 Final approvals and 2 tentative approvals).

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

616.20 17.65 (2.95%)
01-Jan-2026 13:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1718.00
Dr. Reddys Lab 1250.00
Cipla 1500.35
Zydus Lifesciences 912.75
Lupin 2099.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×